Bubble Babies and California Cures: Long-Awaited Good News for One Child and Not-So-Good News on More Funding
Five-month hold on clinical award applications at CIRM
The long-running tale about a cure for the life-threatening bubble baby disease entered a new chapter this month courtesy of California’s stem cell agency.
It was 2020 when the successful therapy was abandoned by the British company that held the exclusive licen…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.